Tech Nation + BioTech Nation + Global BioEntrepreneurship
Episode 26-19Air Date: May 12, 2026
Moira speaks with King’s College London Professor of Political Economy, Anja Shortland, about her book “Dark Screens: Hackers and Heroes in the Shadowy World of Ransomware.” Then, Dr. Jonas Hannestad & Dr. Joanne Taylor discuss how Gain Therapeutics is taking a new approach to treating Parkinson’s by targeting the disease itself. And, Dr. Daniel Kraft shares how he thinks the future of healthcare could be more like a Waymo.
Episode 26-18
Air Date: May 5, 2026
On this week’s Tech Nation, we celebrate the 50th anniversary of the first biotech company to go public, Genentech. Moira speaks with CEO Ashley Magargee about the company’s journey since its founding 50 years ago, and where they’re going next. Then, we remember the life of the late Dr. Craig Venter, whose efforts catalysed the race to decode the first human genome.
Episode 26-17
Air Date: April 30, 2026
On this week’s Tech Nation, Moira speaks with Google’s Data Editor Simon Rogers about the questions we’ve all asked Google over the years…and the surprising truths they reveal about our shared humanity.Then, Andrew Farnum and Sarah Le Baron von Baeyer discuss how Variant Bio aims to forge partnerships with communities not often represented in genomic research. Could studying the genes of isolated populations lead to more effective therapies? And how might they be ethically compensated for their contributions?
BioTech Nation
PODCASTS
May 12, 2026
Remembering Dr. J. Craig Venter
Author, "A Life Decoded: My Genome, My Life"
- With the recent passing of Dr. J. Craig Venter, biotech scientist and entrepreneur, we look back at Moira and David Ewing Duncan's 2007 interview with Dr. Venter. The occasion for the interview was the publication of his autobiography: "A Life Decoded: My Genome, My Life." Dr. Craig Venter was known for catalyzing the race to decode the human genome, and at the time of the interview had just decoded his own complete DNA and published it on the Internet.
May 5, 2026
Ashley Magargee
CEO, Genentech
This week on BioTech Nation, we celebrate the 50th anniversary of Genentech, the first biotech company to go public. Moira speaks with CEO Ashley Magargee about the company's journey over the last 50 years, the evolution of biotech, and where they're headed next.
The J.P. Morgan
Healthcare Conference 2026
5 Companies Ready to
Make A Difference
In San Francisco, biotech entrepreneurs, innovators, and investors from all over the globe are gathering at the 44th Annual J.P. Morgan Healthcare Conference. To coincide with the conference, we’ve put together a special release of 5 BioTech Nation interviews…
These are the JP Morgan Conference 2026 BioTech Nation “5”!
We hear from 5 unique BioTech companies ready to make a difference. Hear their stories directly from the founders, CEOs, and scientists that are making waves in the biotech world:
💡 A New Way to Treat Cancer - Cyriac Roeding & Dr. David Suhy, Earli
💡 A Speedy Intervention for Heart Attacks - Dr. Harry Selker & Atul Deshpande Ph.D., MBA, A-PMP, IMMEDIATE Therapeutics
💡 A Fast-Acting Dupixent? - Dr. Barry Quart, Connect Biopharma
💡 You’ve Had Back Pain for 7-10 Years?- Neil Klompas, Augurex Life Sciences Corp.
💡 A Euphoria-Suppressing Opioid - Ketan Mehta, Tris Pharma
These are the JP Morgan Conference 2026 BioTech Nation “5”!
We hear from 5 unique BioTech companies ready to make a difference. Hear their stories directly from the founders, CEOs, and scientists that are making waves in the biotech world:
💡 A New Way to Treat Cancer - Cyriac Roeding & Dr. David Suhy, Earli
💡 A Speedy Intervention for Heart Attacks - Dr. Harry Selker & Atul Deshpande Ph.D., MBA, A-PMP, IMMEDIATE Therapeutics
💡 A Fast-Acting Dupixent? - Dr. Barry Quart, Connect Biopharma
💡 You’ve Had Back Pain for 7-10 Years?- Neil Klompas, Augurex Life Sciences Corp.
💡 A Euphoria-Suppressing Opioid - Ketan Mehta, Tris Pharma